Skip to content
10-Q

Quarterly Report

Ensysce Biosciences, Inc. ENSC ENSCW

0001641172-25-023512

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 2.97M sh
Stock Issued Q2 2025 · Jun 30, 2025 575.19K sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.2M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.8M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 587.82K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 509.35K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.41M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$5.72M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $2.21M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.5M
Stockholders Equity Q2 2025 · Jun 30, 2025 $3.39M
Stockholders Equity Q2 2025 · Dec 31, 2024 $3.71M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.51M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.21M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.51M
Total Liabilities Q2 2025 · Dec 31, 2024 $2.22M
Current Assets Q2 2025 · Jun 30, 2025 $5.28M
Current Assets Q2 2025 · Dec 31, 2024 $5.34M
Total Assets Q2 2025 · Jun 30, 2025 $5.57M
Total Assets Q2 2025 · Dec 31, 2024 $5.6M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.79
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.04
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.35
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$9.98
Eps Basic Q2 2025 · Jun 30, 2025 −$0.79
Eps Basic Q2 2025 · Jun 30, 2025 −$2.04
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.35
Eps Basic restated Q2 2025 · Jun 30, 2024 −$9.98
Rd Expense Q2 2025 · Jun 30, 2025 $1.92M
Rd Expense Q2 2025 · Jun 30, 2025 $3.81M
Rd Expense Q2 2025 · Jun 30, 2024 $947.23K
Rd Expense Q2 2025 · Jun 30, 2024 $1.73M
Operating Income Q2 2025 · Jun 30, 2025 −$1.75M
Operating Income Q2 2025 · Jun 30, 2025 −$3.72M
Operating Income Q2 2025 · Jun 30, 2024 −$1.96M
Operating Income Q2 2025 · Jun 30, 2024 −$3.8M
Revenue Q2 2025 · Jun 30, 2025 $1.37M
Revenue Q2 2025 · Jun 30, 2025 $2.69M
Revenue Q2 2025 · Jun 30, 2024 $181.8K
Revenue Q2 2025 · Jun 30, 2024 $487.52K